REINA NAJERA: Open Payments
NPI 1821719964 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 16 payments from 5 companies in 2025. Trend: 2023 $143 · 2024 $111 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $164 |
| Sumitomo Pharma America, Inc. | 8 | $147 |
| ABBVIE INC. | 5 | $111 |
| ABC Home Medical Supply, Inc. | 1 | $29 |
| Provepharm Inc. | 1 | $21 |
Products named: Axonics, GEMTESA, BOTOX, LO LOESTRIN FE, BLUDIGO.
Industry payments across MD — which companies pay providers there.
